You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-CDKN1B (CDKN1B) Antibodies

Full name:
anti-Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) Antibodies (CDKN1B)
On www.antibodies-online.com are 632 Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B) Antibodies from 31 different suppliers available. Additionally we are shipping CDKN1B Kits (16) and CDKN1B Proteins (16) and many more products for this protein. A total of 718 CDKN1B products are currently listed.
Synonyms:
1500011J20Rik, 2610202L11Rik, AA408329, AI843786, Bridge-1, Cdki1b, cdkn1b, cdkn1bl, CDKN4, CIB, CIBP, FAM14D, ISG12, ISG12A, Kip1, MEN1B, MEN4, P27, P27KIP1, PRKDCIP, sb:cb611, SIP2-28, wu:fb63g10, wu:fb64g10, wu:fe18e03
list all antibodies Gene Name GeneID UniProt
CDKN1B 10519 Q99828
CDKN1B 12576 P46414
CDKN1B 83571  

Show all species

Show all synonyms

All available anti-CDKN1B Antibodies

Go to our pre-filtered search.

Top referenced anti-CDKN1B Antibodies

  1. Human Polyclonal CDKN1B Primary Antibody for IHC (p), WB - ABIN389614 : Wingate, Zhang, McGarhen, Bedrosian, Harper, Keyomarsi: The tumor-specific hyperactive forms of cyclin E are resistant to inhibition by p21 and p27. in The Journal of biological chemistry 2005 (PubMed)
    Show all 6 references for ABIN389614

  2. Human Polyclonal CDKN1B Primary Antibody for IHC (p), WB - ABIN389617 : Wang, Hou, Mohapatra, Ma, Cress, Pledger, Chen: Activation of p27Kip1 Expression by E2F1. A negative feedback mechanism. in The Journal of biological chemistry 2005 (PubMed)
    Show all 6 references for ABIN389617

  3. Human Polyclonal CDKN1B Primary Antibody for EIA, IHC (p) - ABIN358183 : Kawamata, Inagaki, Mizumura, Sugimoto, Sakajiri, Ohyanagi-Hara, Oshimi: Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders. in European journal of haematology 2005 (PubMed)
    Show all 5 references for ABIN358183

  4. Human Polyclonal CDKN1B Primary Antibody for EIA, IHC (p) - ABIN358185 : Mogensen, Shaw: Current approaches to unravel the mystery of dilated cardiomyopathy, a common cause of hereditary heart failure. in Expert review of proteomics 2005 (PubMed)
    Show all 5 references for ABIN358185

  5. Human Polyclonal CDKN1B Primary Antibody for EIA - ABIN358459 : Andreu, Lledó, Poch, Ivorra, Albero, Martínez-Climent, Montiel-Duarte, Rifón, Pérez-Calvo, Arbona, Prósper, Pérez-Roger: BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells. in Cancer research 2005 (PubMed)
    Show all 5 references for ABIN358459

  6. Human Polyclonal CDKN1B Primary Antibody for ELISA, WB - ABIN1531618 : Polyak, Lee, Erdjument-Bromage, Koff, Roberts, Tempst, Massagué: Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. in Cell 1994 (PubMed)

  7. Cow (Bovine) Polyclonal CDKN1B Primary Antibody for EIA, WB - ABIN782873 : Toyoshima, Hunter: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. in Cell 1994 (PubMed)

More Antibodies against CDKN1B Interaction Partners

Human Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B) interaction partners

  1. Cx43 (show GJA1 Antibodies)-Hsc70 (show HSPA8 Antibodies) interaction regulates cell cycle G1/S progression through a novel mechanism by which Cx43 (show GJA1 Antibodies)-Hsc70 (show HSPA8 Antibodies) interaction prevents the nuclear accumulation of p27 (show PAK2 Antibodies) through controlling the nuclear translocation of cyclin D1 (show CCND1 Antibodies)-CDK4 (show CDK4 Antibodies)-p27 (show PAK2 Antibodies) complex.

  2. These results define a novel mechanism by which PKM2 regulates glioma cell growth, and also define a novel set of potential therapeutic targets along the PKM2-HuR (show ELAVL1 Antibodies)-p27 (show PAK2 Antibodies) pathway

  3. measurements comprising the receptors EGFR (show EGFR Antibodies), ERBB3 (HER3 (show ERBB3 Antibodies)), and the cyclin-dependent kinase inhibitor p27 (CDKN1B) was found to accurately predict dependence on PI3K (show PIK3CA Antibodies)/AKT (show AKT1 Antibodies) vs. MAPK/ERK (show MAPK1 Antibodies) signaling axes in HER2 (show ERBB2 Antibodies)+ cancers

  4. Inhibition of cell cycle entry and progression in a variety of cancers may be achieved with therapies designed to correct p27Kip1 localization and/or block its degradation. (Review)

  5. Suppression of p27Kip1 following increased miR (show MLXIP Antibodies)-150 expression promotes the development and progression of prostate cancer.

  6. eIF3a (show EIF6 Antibodies) improves ovarian cancer patients' response to cisplatin-based chemotherapy by down regulating XPC (show XPC Antibodies) and p27(Kip1).

  7. These findings provide further evidence that histatin 3 (show HTN3 Antibodies) may be involved in the regulation of cell proliferation, particularly during G1/S transition, via the ubiquitin-proteasome system of p27(Kip1) and HSC70 (show HSPA8 Antibodies).

  8. MARCKS (show MARCKS Antibodies) knockdown arrested VSMC cell cycle by decreasing KIS (show UHMK1 Antibodies) expression. Decreased KIS (show UHMK1 Antibodies) expression resulted in nuclear trapping of p27kip1 in VSMCs.

  9. Low expression of KIP1 is associated with Advanced Ovarian Cancer.

  10. Data show that Rheb (show RHEB Antibodies)/p27 (show PAK2 Antibodies) axis induces autophagy-dependent cancer cell survival under stress conditions.

Mouse (Murine) Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B) interaction partners

  1. These results suggest that the abnormal expression of miR222 may contribute to dysregulation of the cellcycle in Alzheimer's disease, at least in part by affecting the expression of p27Kip1.

  2. Data demonstrate that the deletion of cyclin-dependent kinase inhibitor p27 (p27) in parathyroid hormone like hormone (Pthrp (show PTHLH Antibodies)) knock-in(KI/KI (show AXIN1 Antibodies)) mice can partially rescue defects in dental and mandibular development.

  3. Data indicate that an AMP (show TMPRSS5 Antibodies)-ctivated kinase (AMPK (show PRKAA1 Antibodies))/cell-cycle inhibitor (show CDKN2A Antibodies) p27KIP1 (p27) axis drives activation of autophagy in rapamycin-treated tuberous sclerosis 2 protein (Tsc2 (show TSC2 Antibodies))-null cells.

  4. Study shows that SGK1 (show SGK1 Antibodies) impairs nuclear abundance of p27 and suggests that phosphorylation of p27T197 by SGK1 (show SGK1 Antibodies) is required for cardiac hypertrophy.

  5. MARCKS (show MARCKS Antibodies) knockdown arrested VSMC cell cycle by decreasing KIS (show UHMK1 Antibodies) expression. Decreased KIS (show UHMK1 Antibodies) expression resulted in nuclear trapping of p27kip1 in VSMCs.

  6. Report defective erythropoiesis in transgenic mouse with reduced Fbxo7 (show FBXO7 Antibodies) expression due to decreased erythrocyte p27 expression.

  7. Data (including data from studies in knockout/transgenic mice) suggest CDKN1B-RB1 (show RB1 Antibodies)-E2F1 (show E2F1 Antibodies) (CDKN1B-retinoblastoma 1 (show RB1 Antibodies)-E2F transcription factor 1 (show E2F1 Antibodies)) pathway is essential for SSC (show CYP11A1 Antibodies) (spermatogonial stem cell) self-renewal and protection against genomic damage.

  8. A very rapid reduction in p27-phospho-Ser10 levels at the onset of atherogenesis, which contributes to early plaque build-up through RhoA (show RHOA Antibodies)/ROCK-induced integrin expression, is reported.

  9. Sphingomyelin synthase 1 (show SGMS1 Antibodies) regulates Neuro-2a cell proliferation and cell cycle progression through modulation of p27 expression and Akt (show AKT1 Antibodies) signaling

  10. identifies a regulatory axis controlling the G1/S-phase transition, relying on the regulation of MT stability by p27(kip1) and finely controlling the spatiotemporal activation of the Ras-MAPK (show MAPK1 Antibodies) signaling pathway

Pig (Porcine) Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B) interaction partners

  1. FoxO1a (show FOXO1 Antibodies) can regulate p27kip nuclear localization

  2. the activation of Rac1 due to the cell-cell contact plays a critical role in the transcriptional up-regulation of p27Kip1 in vascular endothelial cells.

Cow (Bovine) Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B) interaction partners

  1. p27Kip1 inhibition has an effect on proliferation of bovine corneal endothelial cells by RNA interferenc

Zebrafish Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B) interaction partners

CDKN1B Antigen Profile

Antigen Summary

Important regulator of cell cycle progression. Involved in G1 arrest. Potent inhibitor of cyclin E- and cyclin A-CDK2 complexes. Forms a complex with cyclin type D-CDK4 complexes and is involved in the assembly, stability, and modulation of CCND1- CDK4 complex activation. Acts either as an inhibitor or an activator of cyclin type D-CDK4 complexes depending on its phosphorylation state and/or stoichometry (By similarity).

Alternative names and synonyms associated with CDKN1B

  • cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B) antibody
  • calcium and integrin binding 1 (calmyrin) (CIB1) antibody
  • cyclin kinase inhibitor p30 Kip1 (LOC100689401) antibody
  • cyclin-dependent kinase inhibitor 1B (Cdkn1b) antibody
  • cyclin-dependent kinase inhibitor 1B (p27, Kip1) (Cdkn1b) antibody
  • cyclin-dependent kinase inhibitor 1Ba (cdkn1ba) antibody
  • cyclin-dependent kinase inhibitor 1Bb (cdkn1bb) antibody
  • interferon, alpha-inducible protein 27 (IFI27) antibody
  • proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 (Psmd9) antibody
  • 1500011J20Rik antibody
  • 2610202L11Rik antibody
  • AA408329 antibody
  • AI843786 antibody
  • Bridge-1 antibody
  • Cdki1b antibody
  • cdkn1b antibody
  • cdkn1bl antibody
  • CDKN4 antibody
  • CIB antibody
  • CIBP antibody
  • FAM14D antibody
  • ISG12 antibody
  • ISG12A antibody
  • Kip1 antibody
  • MEN1B antibody
  • MEN4 antibody
  • P27 antibody
  • P27KIP1 antibody
  • PRKDCIP antibody
  • sb:cb611 antibody
  • SIP2-28 antibody
  • wu:fb63g10 antibody
  • wu:fb64g10 antibody
  • wu:fe18e03 antibody

Protein level used designations for CDKN1B

cyclin-dependent kinase inhibitor 1B (p27, Kip1) , cyclin-dependent kinase inhibitor 1B , DNA-PK interaction protein , DNA-PKcs-interacting protein , DNA-dependent protein kinase interacting protein , SNK-interacting protein 2-28 , calcium and integrin-binding protein 1 , Cyclin-dependent kinase inhibitor p27 , cyclin-dependent kinase inhibitor p27 , Cyclin-dependent kinase inhibitor 1B (p27 Kip1) , Cyclin-dependent kinase inhibitor 1B (p27, Kip1) , cyclin-dependent kinase inhibitor p27/Kip1 , p27Kip1 , cyclin-dependent kinase inhibitor 1b, like , kip1 , p27 , cyclin-dependent kinase inhibitor 1b (p27, kip1) , fb64g10 , 2310061N23Rik , ISG12(a) , interferon alpha-induced 11.5 kDa protein , interferon alpha-inducible protein 27, mitochondrial , interferon-stimulated gene 12a protein , 26S proteasome non-ATPase regulatory subunit 9 , 26S proteasome regulatory subunit p27

GENE ID SPECIES
466947 Pan troglodytes
697188 Macaca mulatta
769872 Gallus gallus
100127219 Ovis aries
10519 Homo sapiens
100689401 Cricetulus griseus
12576 Mus musculus
83571 Rattus norvegicus
1027 Homo sapiens
403429 Canis lupus familiaris
374106 Gallus gallus
397584 Sus scrofa
512613 Bos taurus
100729359 Cavia porcellus
493958 Felis catus
402862 Danio rerio
368329 Danio rerio
3429 Homo sapiens
67151 Mus musculus
Selected quality suppliers for anti-CDKN1B (CDKN1B) Antibodies
Did you look for something else?